Skip to main content

Sarepta Therapeutics Inc

For the period ended Dec 31, 2024. Filed Feb 28, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 28, 2025

SRPT$17.24-3.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 2. Properties

A description of the facilities we own and/or occupy is included in the following table. We believe that our current facilities in Cambridge, Andover, Burlington and Bedford, Massachusetts, Columbus, Ohio and Durham, North Carolina are suitable and will provide sufficient capacity to meet the projected needs of our business for the next 12 months. Except as noted below, all of our properties are currently being used in the operation of our business.

Location of PropertySquareFootageLease ExpirationDatePurposeOther Information
215 First Street, Cambridge, MA - 1st & 2nd Floor32,314September 2025Laboratory and office spaceCorporate headquarters
215 First Street, Cambridge, MA - 4th Floor & Basement79,048May 2031Laboratory and office spaceCorporate headquarters
600 Federal Street, Andover, MA11,832December 2026Laboratory and office spaceLaboratory and office space
100 Federal Street, Andover, MA65,589N/A- facility is ownedLaboratory and office spacePrimarily laboratory space
300 Federal Street, Andover, MA23,102December 2025Office spaceOffice space
55 Network Drive, Burlington, MA44,740June 2025Laboratory and office spacePrimarily laboratory space
50-52 Crosby Drive, Bedford, MA288,000January 2038Laboratory and office spacePrimarily laboratory space
3435 Stelzer Road, Columbus, OH151,661December 2036Laboratory and office spacePrimarily laboratory space
701 West Main Street, Suite 102, Durham, NC4,346March 2025Laboratory and office spacePrimarily laboratory space
701 West Main Street, Suite Lab 2806 & 2802, Durham, NC840March 2025Laboratory and office spacePrimarily laboratory space
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.